Abstract
5-Episisomicin, a semisynthetic aminoglycoside, has been shown to inhibit many members of the Enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus aureus. At a concentration of 3.1 μg/ml, more than 90% of Escherichia coli, Klebsiella pneumoniae, Enterobacter, Citrobacter, indole-positive Proteus, and Providencia were inhibited. 5-Episisomicin had activity against S. aureus, E. coli, Klebsiella, Enterobacter, and Citrobacter similar to gentamicin and netilmicin. It had activity similar to amikacin and netilmicin against many gentamicin-resistant bacteria. The activity of 5-episisomicin was greatest at an alkaline pH and in medium of low magnesium content. Synergy of 5-episisomicin and carbenicillin was found to occur most often against Pseudomonas.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benveniste R., Davies J. Mechanisms of antibiotic resistance in bacteria. Annu Rev Biochem. 1973;42:471–506. doi: 10.1146/annurev.bi.42.070173.002351. [DOI] [PubMed] [Google Scholar]
- Fu K. P., Neu H. C. In vitro study of netilmicin compared with other aminoglycosides. Antimicrob Agents Chemother. 1976 Sep;10(3):526–534. doi: 10.1128/aac.10.3.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fu K. P., Neu H. C. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Sep;10(3):511–518. doi: 10.1128/aac.10.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haas M. J., Dowding J. E. Aminoglycoside-modifying enzymes. Methods Enzymol. 1975;43:611–628. doi: 10.1016/0076-6879(75)43124-x. [DOI] [PubMed] [Google Scholar]
- Lee B. K., Condon R. G., Munayyer H., Weinstein M. J. Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells. J Antibiot (Tokyo) 1978 Feb;31(2):141–146. doi: 10.7164/antibiotics.31.141. [DOI] [PubMed] [Google Scholar]
- Neu H. C. Tobramycin: an overview. J Infect Dis. 1976 Aug;134 (Suppl):S3–19. doi: 10.1093/infdis/134.supplement_1.s3. [DOI] [PubMed] [Google Scholar]
- Testa R. T., Wagman G. H., Daniels P. J., Weinstein M. J. Mutamicins; biosynthetically created new sisomicin analogues. J Antibiot (Tokyo) 1974 Dec;27(12):917–921. doi: 10.7164/antibiotics.27.917. [DOI] [PubMed] [Google Scholar]
- Waitz J. A., Miller G. H., Moss E., Jr, Chiu P. J. Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. Antimicrob Agents Chemother. 1978 Jan;13(1):41–48. doi: 10.1128/aac.13.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]